Authors: HAINAUT P AZERAD MA LEHMANN F SCHLIT AF ZECH F HEUSTERSPREUTE M PHILIPPE M COL C LAVENNE E MORIAU M

Citation: P. Hainaut et al., PREVALENCE OF ACTIVATED PROTEIN-C RESISTANCE AND ANALYSIS OF CLINICALPROFILE IN THROMBOEMBOLIC PATIENTS - A BELGIAN PROSPECTIVE-STUDY, Journal of internal medicine, 241(5), 1997, pp. 427-433

Authors: CAPEL P ARNOUT J CAUCHIE P CHATELAIN B CRIEL A DAVID JL FONDU P JOCHMANS K LAVENNE E LUST A VANDERPLANKEN M

Citation: P. Capel et al., COMPARATIVE-STUDY OF ANTIPHOSPHOLIPID ANTIBODY DETECTION IN 11 BELGIAN LABORATORIES, Acta Clinica Belgica, 52(2), 1997, pp. 84-91

Authors: HOUBOUYAN L BONVARLET MN COMBY S SANVERT M RAGEADE C DUPUY G GOQUEL A BOUTIERE B CARMAGNOL F DROULLE C HOUBOUYAN L LAVENNE E MARION S POTRON G

Citation: L. Houbouyan et al., INR STANDARDIZATION BY THE CALIBRATED PLASMA PROCEDURE (CPP), Thrombosis and haemostasis, 73(6), 1995, pp. 1238-1238

Authors: SCHLIT AF GRANDJEAN P DONNEZ J LAVENNE E

Citation: Af. Schlit et al., LARGE INCREASE IN PLASMATIC 11-DEHYDRO-TXB2 LEVELS DUE TO ORAL-CONTRACEPTIVES, Contraception, 51(1), 1995, pp. 53-58

Authors: ELKHAWAND C JAMART J DONCKIER J CHATELAIN B LAVENNE E MORIAU M BUYSSCHAERT M

Citation: C. Elkhawand et al., HEMOSTASIS VARIABLES IN TYPE-I DIABETIC-PATIENTS WITHOUT DEMONSTRABLEVASCULAR COMPLICATIONS, Diabetes care, 16(8), 1993, pp. 1137-1145